Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 148, Issue , 2016, Pages 363-370

  Nag, Mukesh ^a   Gajbhiye, Virendra ^a,b   Kesharwani, Prashant ^c   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b AGHARKAR RESEARCH INSTITUTE   (India)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Chitosan nanoparticles; Paclitaxel; Polyethylene glycol; Targeted drug delivery; Transferrin

Indexed keywords

CELL CULTURE; CHITIN; CHITOSAN; CYTOLOGY; CYTOTOXICITY; DISEASES; MOLECULAR BIOLOGY; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENES;

CHITOSAN NANOPARTICLES; NON SMALL CELL LUNG CANCER; PACLITAXEL; PEGYLATED NANOPARTICLE; SOLVENT EVAPORATION METHOD; TARGETED DRUG DELIVERY; TRANSFERRIN; TRANSFERRIN RECEPTORS;

CELLS;

AMINE; CHITOSAN NANOPARTICLE; HYDROXYL GROUP; LIGAND; MACROGOL; NANOPARTICLE; PACLITAXEL; TRANSFERRIN; TRANSFERRIN RECEPTOR; ANTINEOPLASTIC AGENT; CHITOSAN; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER CELL LINE; CELL NUCLEUS; CONJUGATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOCYTOSIS; EVAPORATION; HUMAN; HUMAN CELL; MAXIMUM PLASMA CONCENTRATION; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; AREA UNDER THE CURVE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; INFRARED SPECTROSCOPY; LUNG TUMOR; METABOLISM; PARTICLE SIZE; PATHOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG DELIVERY SYSTEMS; HUMANS; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RECEPTORS, TRANSFERRIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE DISTRIBUTION; TRANSFERRIN;

EID: 84987650346     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.08.059     Document Type: Article

References (23)

1. [1] Luong, D., Kesharwani, P., Deshmukh, R., Mohd Amin, M.C.I., Gupta, U., Greish, K., Iyer, A.K., PEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Acta Biomater., 2016, 10.1016/j.actbio.2016.07.015 (in press).
2. [2] Perrault, S.D., Walkey, C., Jennings, T., Fischer, H.C., Chan, W.C., Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9 (2009), 1909–1915.
3. [3] Park, J.W., Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer. 8 (2002), 1172–1181.
4. [4] Maruyama, K., Ishida, O., Kasaoka, S., Takizawa, T., Utoguchi, N., Shinohara, A., Chiba, M., Kobayashi, H., Eriguchi, M., Yanagie, H., Intracellular targeting of sodium mercaptounde-cahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J. Control. Release 98 (2004), 195–207.
5. [5] Kursa, M., Walker, G.F., Roessler, V., Ogris, M., Roedl, W., Kircheis, R., Wagner, E., Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. 14 (2003), 222–231.
6. [6] Jiang, Y.Y., Liu, C., Hong, M.H., Zhu, S.J., Pei, Y.Y., Tumor cell targeting of transferrin- PEG TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation. Bioconjug. Chem. 18 (2007), 41–49.
7. [7] Kavimandan, N.J., Losi, E., Peppas, N.A., Novel delivery system based on complexation hydrogels as delivery vehicles for insulin–transferrin conjugates. Biomaterials 27 (2006), 3846–3854.
8. [8] Lai, H., Sasaki, T., ingh, N.P., Messay, A., Effects of artemisinin-taggedholotransferrinon cancer cells. Life Sci. 76 (2005), 1267–1279.
9. [9] Cardoso, A.L.C., Simoes, S., Almeida, L.P., Plesnila, N., Pedroso Culmsee, C., Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. J. Control. Release 132 (2008), 113–123.
10. [10] Kakimoto, S., Moriyama, T., Tanabe, T., Shinkai, S., Nagasaki, T., Dual-ligand effect of transferrin and transforming growth factor alpha on polyethyleneimine-mediated gene delivery. J. Control. Release 120 (2007), 242–249.
11. [11] Chiu, S.J., Liu, S.J., Perrotti, D., Marcucci, G., Lee, R.J., Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J. Control. Release 112 (2006), 199–207.
12. [12] Sakaguchi, N., Kojima, C., Harada, A., Koiwai, K., Shimizu, K., Emi, N., Kono, K., Enhancement of transfection activity of lipoplexes by complexation with transferrin-bearing fusogenic polymer-modified liposomes. Int. J. Pharm. 325 (2006), 186–190.
13. [13] Kakudo, T., Chaki, S., Futaki, S., Nakase, I., Akaji, K., Kawakami, T., Maruyama, K., Kamiya, H., Harashima, H., Transferrin-modified liposomes equippedwith apH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 43 (2004), 5618–5628.
14. [14] Dubey, M., Kesharwani, P., Tiwari, A., Chandel, R., Raja, K., Sivakumar, T., Formulation and evaluation of floating microsphere containing anti diabetic drug. Int. J. Pharm. Chem. Sci. 1 (2012), 1038–1047.
15. [15] Pan, X., Guan, J., Yoo, J.W., Epstein, A.J., Lee, L.J., Lee, R.J., Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int. J. Pharm. 358 (2008), 263–270.
16. [16] Mishra, V., Kesharwani, P., Dendrimer technologies for brain tumor. Drug Discov. Today 21 (2016), 766–778.
17. [17] Govender, P., Dhanalekshmi, D.M., Narayanan, N., Reddy, P.N., Preparation and characterization of repaglinide loaded chitosan polymeric nanoparticles. Res. J. Nanosci. Nanotechnol. 1 (1999), 12–24.
18. [18] Gajbhiye, V., Jain, N.K., The treatment of glioblastoma xenografts by surfactant conjugated dendritic Nanoconjugates. Biomaterials, 2011, 1–13.
19. [19] Lima, E.K., Yang, J., Park, M., Park, J., Suh, J.S., Yoon, H.G., Synthesis of water soluble PEGylated magnetic complexes using mPEG-fatty acid for biomedical applications. Colloids Surf. B Biointerfaces 64 (2008), 111–117.
20. [20] Yang, A., Yang, L., Liu, W., Li, Z., Xu, H., Yang, X., Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Int. J. Pharm. 331 (2007), 123–132.
21. [21] Gan, C.W., Feng, S.S., Transferrin-conjugated nanoparticles of poly(lactide)-D-a-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the bloodebrain barrier. Biomaterials 31 (2010), 7748–7757.
22. [22] Gajbhiye, V., Kumar, P.V., Sharma, A., Jain, N.K., Novel PEGylated PPI dendritic nanostructures for sustained delivery of anti-inflammatory agent. Curr. Nanosci. 4 (2008), 267–277.
23. [23] Thakur, S., Kesharwani, P., Tekade, R.K., Jain, N.K., The effect of polyethylene glycol spacer chain length on the tumor targeting potential of folate modified PPI dendrimers. J. Nanopart. Res., 15, 2013, 1625.